Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidase is not a specific molecule or receptor, but rather a general term for a large class of enzymes. It refers to any enzyme that catalyzes oxidation-reduction reactions using molecular oxygen (O₂) as the electron acceptor. There is no universal abbreviation for "oxidase" as it refers to many different enzymes. Specific oxidases have their own abbreviations (e.g., MAO for monoamine oxidase, COX for cytochrome c oxidase). "Oxidase" by itself does not refer to a single therapeutic target, but rather an entire class of enzymes with diverse biological roles and drug interactions. Individual members of the oxidase family can be therapeutic targets. The term "oxidase" is too broad and non-specific to represent a unique drug target or receptor; it encompasses many distinct enzymes with different functions and clinical relevance. For structured data purposes, you should specify which particular oxidase (e.g., monoamine oxidase, xanthine oxidase) you are interested in. In biochemistry, an oxidase is any enzyme that catalyzes oxidation-reduction reactions using dioxygen (O₂) as the electron acceptor, resulting in reduction to water (H₂O) or hydrogen peroxide (H₂O₂). This group includes many unrelated proteins scattered across several subclasses within EC Class 1 ("Oxidoreductases"). Examples include cytochrome c oxidase—the terminal component in mitochondrial electron transport chain—as well as glucose-, monoamine-, xanthine-, lysyl-, polyphenol-, diamine-, and sulfhydryl oxidases. Each has distinct structure/function/disease associations. The term “oxidase” alone does not specify one protein/receptor/molecule suitable for structured database use without further context.
Drugs typically act by inhibiting or modulating activity of individual members within this class—mechanisms include competitive inhibition at active sites or allosteric modulation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidase (enzyme).